Enhanced Bacteremia in Human Factor H Transgenic Rats Infected by Neisseria meningitidis
Open Access
- 1 February 2012
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 80 (2) , 643-650
Abstract
Neisseria meningitidisbinds the complement downregulating protein, factor H (fH), which enables the organism to evade host defenses. Two fH ligands, fHbp and NspA, are known to bind specifically to human fH. We developed a human fH transgenic infant rat model to investigate the effect of human fH on meningococcal bacteremia. At 18 h after intraperitoneal challenge with 560 CFU of group B strain H44/76, all 19 human fH-positive rats had positive blood cultures compared to 0 of 7 human fH-negative control littermates (P< 0.0001). Human fH-positive infant rats also developed bacteremia after challenge with isogenic mutants of H44/76 in which genes encoding fHbp and NspA (ΔfHbp ΔNspA mutant) or the lipooligosaccharide sialyltransferase (Δlstmutant) had been inactivated. A fully encapsulated ΔfHbp ΔNspA Δlstmutant unable to sialylate lipooligosaccharide or bind human fH via the known fH ligands did not cause bacteremia, which argued against global susceptibility to bacteremia resulting from random integration of the transgene into the rat genome.In vitro, the wild-type and ΔfHbp ΔNspA mutant strains were killed by as little as 20% wild-type infant rat serum. The addition of 3 μg of human fH/ml permitted survival of the wild-type strain in up to 60% infant rat serum, whereas ≥33 μg of human fH/ml was required to rescue the ΔfHbp ΔNspA mutant. The ability of meningococci lacking expression of fHbp and NspA to cause invasive disease in human fH transgenic rats and to survive in wild-type infant rat serum supplemented with human fH indicates an additional human fH-dependent mechanism of evasion of innate immunity.Keywords
This publication has 38 references indexed in Scilit:
- Linkage Specificity and Role of Properdin in Activation of the Alternative Complement Pathway by Fungal GlycansmBio, 2011
- Complement-Mediated Bactericidal Activity of Anti-Factor H Binding Protein Monoclonal Antibodies against the Meningococcus Relies upon Blocking Factor H BindingInfection and Immunity, 2011
- Effect of Factor H-Binding Protein Sequence Variation on Factor H Binding and Survival ofNeisseria meningitidisin Human BloodInfection and Immunity, 2011
- The Meningococcal Vaccine Candidate Neisserial Surface Protein A (NspA) Binds to Factor H and Enhances Meningococcal Resistance to ComplementPLOS Pathogens, 2010
- An Evaluation of the Role of Properdin in Alternative Pathway Activation on Neisseria meningitidis and Neisseria gonorrhoeaeThe Journal of Immunology, 2010
- Binding of Complement Factor H (fH) to Neisseria meningitidis Is Specific for Human fH and Inhibits Complement Activation by Rat and Rabbit SeraInfection and Immunity, 2009
- Defining Targets for Complement Components C4b and C3b on the Pathogenic NeisseriaeInfection and Immunity, 2008
- Transgenic Mice Expressing Human Transferrin as a Model for Meningococcal InfectionInfection and Immunity, 2007
- Immunity to Neisseria meningitidis Group B in Adults despite Lack of Serum Bactericidal AntibodyClinical and Vaccine Immunology, 2007
- Neisserial Outer Membrane Vesicles Bind the Coinhibitory Receptor Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 1 and Suppress CD4 + T Lymphocyte FunctionInfection and Immunity, 2007